Arbutus Biopharma公司今日宣布,计划以修改版“荷兰式拍卖”要约收购方式,回购总价值高达2.3亿美元的普通股。这一举措旨在优化资本结构,提升股东价值。
Arbutus Biopharma公司今日宣布,计划以修改版“荷兰式拍卖”要约收购方式,回购总价值高达2.3亿美元的普通股。这一举措旨在优化资本结构,提升股东价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.